This information was published on 2025-12-19T15:30:12 for IP Right Filed Published.
| Field | Value |
| (210) | 2613952 |
| (220) |
19 Dec 2025
|
| (300) |
US, 10 Nov 2025, 99488513
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants. |
| (540) | UPCLIXIOR |
| (550) | Word |
| (730) |
Bristol-Myers Squibb Company
|
| (750) |
Spruson & Ferguson
|
Find out more about publications on the About page.